Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882492 · ClinicalTrials.gov registry record · Phase 1
GLP 1 for Intraoperative Glycemic Control
A Phase 1 study of Hypoglycemia and Hyperglycemia, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT00882492: Completed Phase 1 study of Hypoglycemia and Hyperglycemia, sponsored by University of Pennsylvania.
NCT00882492 is a Phase 1 study of Hypoglycemia and Hyperglycemia that has completed, run by University of Pennsylvania. The registered enrollment target is 80 participants, below the 505-participant average among 40 other Hypoglycemia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00882492, a Phase 1 study of Hypoglycemia and Hyperglycemia, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a medical research study designed to see if an infusion of a naturally occurring hormone, GLP-1, works when used to decrease blood sugar during cardiac surgery.
Conditions Studied
Interventions
- BIOLOGICAL GLP 1
- BIOLOGICAL normal saline solution placebo
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
What the finished NCT00882492 record still lists
NCT00882492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 505-participant average among 40 other Hypoglycemia trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Hypoglycemia appearing as the primary indexed condition, and to 2 interventions - of which GLP 1 is the first listed.
NCT00882492 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00882492 about?
NCT00882492 is a clinical study titled "GLP 1 for Intraoperative Glycemic Control". This is a medical research study designed to see if an infusion of a naturally occurring hormone, GLP-1, works when used to decrease blood sugar during cardiac surgery.
What is the current status of trial NCT00882492?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2008-12. Estimated completion is 2011-05.
What conditions does trial NCT00882492 study?
This clinical trial studies the following conditions: Hypoglycemia, Hyperglycemia.
What interventions are being tested in trial NCT00882492?
The interventions under investigation include: GLP 1 (BIOLOGICAL), normal saline solution placebo (BIOLOGICAL).
Who is sponsoring clinical trial NCT00882492?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00882492 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00882492's enrollment target sits among peer trials
80 12th of 40 higher than 29 of 40 other Hypoglycemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoglycemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients
COMPLETED · Phase 1
-
External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia
RECRUITING
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
RECRUITING · NA
-
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia